Trial
NCT00003452
Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Burzynski Research Institute
Collaborators
—
Condition
Stage IV Bladder Cancer
Intervention
Antineoplaston therapy (Atengenal + Astugenal)
Why stopped
slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-28